CoChat

Colorectal Cancer Cell Lines Are Representative Models of the Main Molecular Subtypes of Primary Cancer

Published version of a preprint

The DOI matches its Crossref record; 47 of the 49 references it cites were found in a registry or an index.

Abstract

Human colorectal cancer cell lines are used widely to investigate tumor biology, experimental therapy, and biomarkers. However, to what extent these established cell lines represent and maintain the genetic diversity of primary cancers is uncertain. In this study, we profiled 70 colorectal cancer cell lines for mutations and DNA copy number by whole-exome sequencing and SNP microarray analyses, respectively. Gene expression was defined using RNA-Seq. Cell line data were compared with those published for primary colorectal cancers in The Cancer Genome Atlas. Notably, we found that exome mutation and DNA copy-number spectra in colorectal cancer cell lines closely resembled those seen in primary colorectal tumors. Similarities included the presence of two hypermutation phenotypes, as defined by signatures for defective DNA mismatch repair and DNA polymerase ϵ proofreading deficiency, along with concordant mutation profiles in the broadly altered WNT, MAPK, PI3K, TGFβ, and p53 pathways. Furthermore, we documented mutations enriched in genes involved in chromatin remodeling (ARID1A, CHD6, and SRCAP) and histone methylation or acetylation (ASH1L, EP300, EP400, MLL2, MLL3, PRDM2, and TRRAP). Chromosomal instability was prevalent in nonhypermutated cases, with similar patterns of chromosomal gains and losses. Although paired cell lines derived from the same tumor exhibited considerable mutation and DNA copy-number differences, in silico simulations suggest that these differences mainly reflected a preexisting heterogeneity in the tumor cells. In conclusion, our results establish that human colorectal cancer lines are representative of the main subtypes of primary tumors at the genomic level, further validating their utility as tools to investigate colorectal cancer biology and drug responses. Cancer Res; 74(12); 3238–47. ©2014 AACR.

Overview

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-14-0013

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 47 references

Cited by

See all 418

Metadata

Authors
Mouradov, D., Sloggett, C., Jorissen, R. N., Love, C. G., Li, S., Burgess, A. W., Arango, D., Strausberg, R. L., Buchanan, D., Wormald, S., O'Connor, L., Wilding, J. L., Bicknell, D., Tomlinson, I. P. M., Bodmer, W. F., Mariadason, J. M., & Sieber, O. M.
Affiliations
  • Universitat Autònoma de Barcelona (ES)
  • Authors' Affiliations: 1Ludwig Institute for Cancer Research; 2Systems Biology and Personalised Medicine Division; 3Structural Biology Division; Walter and Eliza Hall Institute of Medical Research; 4Faculty of Medicine, Dentistry and Health Sciences, Department of Medical Biology, University of Melbourne, Parkville; 5VLSCI Life Sciences Computation Centre, a collaboration between Melbourne, Monash and LaTrobe Universities, c/o The University of Melbourne, Carlton; 6Oncogenic Transcription Laboratory, Ludwig Institute for Cancer Research, Austin, VIC, Australia; 7Cancer and Population Studies Group, Queensland Institute of Medical Research, Herston, QLD, Australia; 8Group of Molecular Oncology, CIBBIM-Nanomedicine, Vall d'Hebron University Hospital, Research Institute (VHIR), Universitat Autònoma de Barcelona, Passeig Vall d'Hebron, 119-129, 08035 Barcelona; 9CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN); Spain; 10Ludwig Collaborative Laboratory for Cancer Biology and Therapy, Department of
Venue
Cancer Research
Published
2014-06-12
Volume
74
Issue
12
Pages
3238-3247
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2154312575
Cited by
375
References
49
Citations by year
2026: 11 · 2025: 17 · 2024: 35 · 2023: 28 · 2022: 31 · 2021: 49 · 2020: 40 · 2019: 32 · 2018: 32 · 2017: 36 · 2016: 35 · 2015: 21 · 2014: 7
FWCI
24.50
Type
journal article
Language
en
Open access
closed
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Deutsches Krebsforschungszentrum
  • Wellcome Trust (090532)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
Keywords
colorectal cancer cell lines, molecular subtypes, tumor genomic heterogeneity, somatic mutations, DNA copy number alterations, mismatch repair deficiency, chromosomal instability, chromatin remodeling genes, histone modification genes, Wnt signaling, MAPK signaling, PI3K signaling, TGF-beta signaling, p53 pathway
MeSH terms
Chromosome Aberrations, DNA Mutational Analysis, Gene Frequency, Humans, Colorectal Neoplasms, Gene Dosage, Cell Line, Tumor, Genes, Neoplasm, Microsatellite Instability, DNA Copy Number Variations, Transcriptome, Exome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Colorectal Cancer Cell Lines Are Representative Models of the Main Molecular Subtypes of Primary Cancer. https://app.cochat.ai/papers/10.1158/0008-5472.can-14-0013
The paper
Mouradov, D., Sloggett, C., Jorissen, R. N., Love, C. G., Li, S., Burgess, A. W., Arango, D., Strausberg, R. L., Buchanan, D., Wormald, S., O'Connor, L., Wilding, J. L., Bicknell, D., Tomlinson, I. P. M., Bodmer, W. F., Mariadason, J. M., & Sieber, O. M. (2014). Colorectal Cancer Cell Lines Are Representative Models of the Main Molecular Subtypes of Primary Cancer. Cancer Research. https://doi.org/10.1158/0008-5472.can-14-0013

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.